Cargando…

Oncogenic long noncoding RNA FAL1 in human cancer

Long non-coding RNAs (lncRNAs) are defined as RNA transcripts larger than 200 nucleotides that do not appear to have protein-coding potential. Accumulating evidence indicates that lncRNAs are involved in tumorigenesis. Our work reveals that lncRNA FAL1 (focally amplified lncRNA on chromosome 1) is f...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhong, Xiaomin, Hu, Xiaowen, Zhang, Lin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Taylor & Francis 2015
Materias:	Author'S View
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4905162/ https://www.ncbi.nlm.nih.gov/pubmed/27308441 http://dx.doi.org/10.4161/23723556.2014.977154

Ejemplares similares

Pinched by RNA “fingers”: Long noncoding RNAs hitting signal transduction pathways
por: Liu, Bodu, et al.
Publicado: (2016)

ERBB2 oncogenicity: ERBIN helps to perform the job
por: Mei, Lin, et al.
Publicado: (2015)

Untargeted metabolomics for profiling oncogene-specific metabolic signatures of prostate cancer
por: Priolo, Carmen, et al.
Publicado: (2015)

ADHFE1 is a MYC-linked oncogene that induces metabolic reprogramming and cellular de-differentiation in breast cancer
por: Mishra, Prachi, et al.
Publicado: (2018)

Next-generation sequencing identified new oncogenes and tumor suppressor genes in human hepatic tumors
por: Amaddeo, Giuliana, et al.
Publicado: (2012)

Oncogenic regulatory circuits driven by 19q13 rs11672691 underlies prostate cancer aggressiveness
por: Xia, Ji-Han, et al.
Publicado: (2018)

Overexpression of the Fork Protection Complex: a strategy to tolerate oncogene-induced replication stress in cancer cells
por: Pasero, Philippe, et al.
Publicado: (2019)

Strong emerging rationale for combining oncogene-targeted agents with immunotherapy
por: Yang, Yan, et al.
Publicado: (2013)

Forging a link between oncogenic signaling and immunosuppression in melanoma
por: Khalili, Jahan S., et al.
Publicado: (2013)

NKG2D ligands link oncogenic RAS to innate immunity
por: Ho, Samantha S.W., et al.
Publicado: (2013)

MHC-I genotype drives early immune selection of oncogenic mutations
por: Marty, Rachel, et al.
Publicado: (2018)

Ewing sarcoma fusion oncogene: At the crossroads of transcription and DNA damage response
por: Gorthi, Aparna, et al.
Publicado: (2018)

Oncogenic β-catenin mutations evade pH-regulated degradation
por: Grillo-Hill, Bree K., et al.
Publicado: (2019)

Relationship of Focally Amplified Long Noncoding on Chromosome 1 (FAL1) lncRNA with E2F Transcription Factors in Thyroid Cancer
por: Jeong, Seonhyang, et al.
Publicado: (2016)

Fateful music from a talented orchestra with a wicked conductor: Connection between oncogenic BRAF, ER stress, and autophagy in human melanoma
por: Giglio, Paola, et al.
Publicado: (2015)

RNA helicase DP103 and TAK1: a new connection in cancer
por: Shin, Eun Myoung, et al.
Publicado: (2015)

Insulin receptor substrate 4 (IRS4) is a constitutive active oncogenic driver collaborating with HER2 and causing therapeutic resistance
por: Ikink, Gerjon J., et al.
Publicado: (2017)

WNT-mediated gene gating: a novel principle connecting oncogenic super-enhancers with the nuclear pore to drive pathological expression of MYC
por: Göndör, Anita
Publicado: (2020)

Unraveling the therapeutic potential of the LncRNA-dependent noncanonical Hedgehog pathway in cancer
por: Xing, Zhen, et al.
Publicado: (2015)

Chemoimmunotherapy as long-term maintenance therapy for cancer
por: Egilmez, Nejat K., et al.
Publicado: (2012)

The pan-cancer lncRNA MILIP links c-Myc to p53 repression
por: Feng, Yu Chen, et al.
Publicado: (2020)

A novel miRNA-mediated STOP sign in lung cancer: miR-340 inhibits the proliferation of lung cancer cells through p27(KIP1)
por: Fernandez, Serena, et al.
Publicado: (2015)

Expression profile of the human IDO1 protein, a cancer drug target involved in tumoral immune resistance
por: Vigneron, Nathalie, et al.
Publicado: (2015)

Novel function of STAT1 in breast cancer
por: Zhang, Ming
Publicado: (2013)

HIF-1 suppresses lipid catabolism to promote cancer progression
por: Zhang, Huafeng
Publicado: (2015)

The immune landscape of human tumors: Implications for cancer immunotherapy
por: Bindea, Gabriela, et al.
Publicado: (2014)

Long peptide-based cancer immunotherapy targeting tumor antigen-specific CD4(+) and CD8(+) T cells
por: Tomita, Yusuke, et al.
Publicado: (2013)

Human Th17 cells in patients with cancer: Friends or foe?
por: Greten, Tim F., et al.
Publicado: (2012)

Single cell RNA-seq highlights a role for a partial EMT in head and neck cancer
por: Puram, Sidharth V., et al.
Publicado: (2018)

The PVT1-MYC duet in cancer
por: Tseng, Yuen-Yi, et al.
Publicado: (2015)

CircZNF609 as a prototype to elucidate the biological function of circRNA-mRNA interactions
por: Beltran, Manuel, et al.
Publicado: (2022)

Targeting cancer stem cells with ALDH1A1-based immunotherapy
por: DeLeo, Albert B.
Publicado: (2012)

Controlling the mitochondrial antisense – role of the SUV3-PNPase complex and its co-factor GRSF1 in mitochondrial RNA surveillance
por: Pietras, Zbigniew, et al.
Publicado: (2018)

BRCA1: a movement toward cancer prevention
por: Alli, Elizabeth, et al.
Publicado: (2015)

Tertiary lymphoid structures in human lung cancers, a new driver of antitumor immune responses
por: Goc, Jérémy, et al.
Publicado: (2014)

Identification of human tissue cross-presenting dendritic cells: A new target for cancer vaccines
por: Haniffa, Muzlifah, et al.
Publicado: (2013)

Roadblocks to success for RNA CARs in solid tumors
por: Singh, Nathan, et al.
Publicado: (2015)

Stromal CEACAM1 expression regulates colorectal cancer metastasis
por: Arabzadeh, Azadeh, et al.
Publicado: (2012)

SAMHD1 is a barrier to antimetabolite-based cancer therapies
por: Rudd, Sean G., et al.
Publicado: (2017)

SRC promotes lipogenesis: implications for obesity and breast cancer
por: Lin, Shu-Yong, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_hj2pladvh7k9o0vkelg3qs3lt9